SEC Form 4Coverage since Jun 4, 2026
$INKT insider trading
Over the last 12 months, MiNK Therapeutics insiders reported no purchases and 2 sales totaling $19K across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $19K 2 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $INKT · 12Mvia TradingView
Top insiders · 12m
Ryan Barbara—2× · $19K
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Ryan BarbaraD | ▼ Sale | 1,000 | $12.8 | $13K | -4.4% | — |
| Jun 4, 2026 | Ryan BarbaraD | ▼ Sale | 500 | $12.68 | $6K | -2.1% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $INKT feed.